Manganese superoxide dismutase in disease
- 1 January 2001
- journal article
- review article
- Published by Informa UK Limited in Free Radical Research
- Vol. 34 (4), 325-336
- https://doi.org/10.1080/10715760100300281
Abstract
Manganese superoxide dismutase (MnSOD) is essential for life as dramatically illustrated by the neonatal lethality of mice that are deficient in MnSOD. In addition, mice expressing only 50% of the normal compliment of MnSOD demonstrate increased susceptibility to oxidative stress and severe mitochondrial dysfunction resulting from elevation of reactive oxygen species. Thus, it is important to know the status of both MnSOD protein levels and activity in order to assess its role as an important regulator of cell biology. Numerous studies have shown that MnSOD can be induced to protect against pro-oxidant insults resulting from cytokine treatment, ultraviolet light, irradiation, certain tumors, amyotrophic lateral sclerosis, and ischemia/reperfusion. In addition, overexpression of MnSOD has been shown to protect against pro-apoptotic stimuli as well as ischemic damage. Conversely, several studies have reported declines in MnSOD activity during diseases including cancer, aging, progeria, asthma, and transplant rejection. The precise biochemical/molecular mechanisms involved with this loss in activity are not well understood. Certainly, MnSOD gene expression or other defects could play a role in such inactivation. However, based on recent findings regarding the susceptibility of MnSOD to oxidative inactivation, it is equally likely that post-translational modification of MnSOD may account for the loss of activity. Our laboratory has recently demonstrated that MnSOD is tyrosine nitrated and inactivated during human kidney allograft rejection and human pancreatic ductal adenocarcinoma. We have determined that peroxynitrite (ONOO-) is the only known biological oxidant competent to inactivate enzymatic activity, to nitrate critical tyrosine residues, and to induce dityrosine formation in MnSOD. Tyrosine nitration and inactivation of MnSOD would lead to increased levels of superoxide and concomitant increases in ONOO- within the mitochondria which, could lead to tyrosine nitration/oxidation of key mitochondrial proteins and ultimately mitochondrial dysfunction and cell death. This article assesses the important role of MnSOD activity in various pathological states in light of this potentially lethal positive feedback cycle involving oxidative inactivation.Keywords
This publication has 68 references indexed in Scilit:
- Manganese Superoxide Dismutase Levels Are Elevated in a Proportion of Amyotrophic Lateral Sclerosis Patient Cell LinesBiochemical and Biophysical Research Communications, 2000
- Altered Levels of Primary Antioxidant Enzymes in Progeria Skin FibroblastsBiochemical and Biophysical Research Communications, 1999
- Analysis of Mitochondrial Targeting Sequence and Coding Region Polymorphisms of the Manganese Superoxide Dismutase Gene in German Parkinson Disease PatientsBiochemical and Biophysical Research Communications, 1999
- Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cellsOncogene, 1999
- Role of Oxidants in Ischemic Brain DamageStroke, 1996
- Mitochondrial Generation of Reactive Oxygen Species After Brain Ischemia in the RatStroke, 1996
- Regulation of manganese superoxide dismutase in glomerular epithelial cells: Mechanisms for interleukin 1 inductionKidney International, 1995
- Protective roles of cytokines against radiation: Induction of mitochondrial MnSODBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- Overexpression of manganous superoxide dismutase (MnSOD) in pulmonary endothelial cells confers resistance to hyperoxiaJournal of Cellular Physiology, 1994
- Mn and Cu/Zn SOD expression in cells from LPS-sensitive and LPS-resistant miceFree Radical Biology & Medicine, 1992